LEU— AI Stock Forecast & Price Targets
Published 7/23/2026 · A free sample of K3vl4r’s AI-powered analysis.
Kronos price forecasts, scored fundamentals & technicals, and a multi-horizon plan.
View the live LEU price forecast →
Centrus retains a genuinely scarce asset — sole U.S.-licensed HALEU enricher with a $1.07B DOE contract, $900M Piketon task order, and $1.87B cash — but at $174 it trades ~44x forward with $58M/quarter FCF burn and a binary Aug 4 earnings print 12 days out. The bounce off the $142-$147 zone has retraced back to the 50DMA and prior supply, and with the model's directional accuracy running below naive baseline on both 1d and 1wk, this is a HOLD into the print rather than a fresh entry.
HOLD into Aug 4 earnings — do NOT initiate a swing trade across the print. Q2 gross margin repeatability vs Q1'26's 41% is the entire event. If already long, consider trimming 25-33% here at $174 into resistance ($172-$180 supply); leave core for the print. New entries only on either (a) a pullback to $158-$162 with volume dry-up pre-print, or (b) a post-print confirmed close above $185 on strong margin/FCF beat. Invalidation for any long bias: weekly close below $144.
1-6 month base case is range-bound $150-$210 with the Aug 4 print as the pivot. Bull case ($215-$240) requires Q2 gross margin >30%, positive operating cash flow, and no ATM utilization commentary. Bear case ($120-$145) triggers on margin reversion, capex overrun guidance, or ATM activation. Expected return range from $174: -17% to +23%, skewed slightly negative given valuation. Mind-changers: a concrete SMR offtake (Oklo, X-energy) would add ~$20-30 of durable value; ATM issuance would remove the cash-cushion argument.
1-3 year thesis is intact and asymmetric to the upside IF Piketon transitions to stable commercial HALEU production by 2027 and SMR deployment ramps as forecast. Centrus is a call option on U.S. nuclear fuel independence — the moat (NRC license, DOE relationship, only domestic HALEU line) is genuinely scarce and not easily replicated. Fair value in a successful execution scenario is $250-$350 based on SMR offtake economics; failure scenario (capex overruns, SMR delays, ATM dilution) is $80-$120. Biggest structural risk: the SMR commercialization curve slips 2-3 years, leaving Centrus burning cash against a customer base that hasn't materialized.
Revenue is lumpy and decelerating on a TTM basis (Sales Y/Y TTM -4.05%): Q1'26 came in at $76.7M vs Q4'25 $146.2M and Q2'25 $154.5M, driven by SWU delivery timing rather than underlying demand shifts. The bright spot is Q1'26 gross margin at 41.1% — a huge step-up from Q3'25's -5.7% — but operating margin was barely positive at 1.0% and TTM operating margin sits at -0.26%, meaning the P&L profit ($60.6M TTM, 13.4% net margin) is being carried by non-operating items rather than core enrichment economics. Balance sheet is the real strength: $1.87B cash vs $1.18B debt (net cash ~$690M, or ~$36/share), current ratio 5.72, and stockholders' equity jumped from $359M at Q2'25 to $775M at Q1'26 (equity raise footprint). Cash flow is the broken piece — operating cash flow -$35.1M and FCF -$58.3M in Q1'26, with capex ramping to $23.2M as Piketon scales; TTM FCF is negative and the ATM shelf remains a latent dilution overhang. Valuation is stretched — 57.7x trailing / 44.2x forward P/E, 7.6x P/S, 66.6x EV/EBITDA — which leaves essentially no cushion if Q2 margins revert toward Q3'25 levels.
The multi-timeframe picture is a classic post-parabola consolidation. On the weekly, LEU peaked near $380 and has retraced ~55% to $170, but sits well above the $50-$100 pre-breakout base — structurally intact but with heavy overhead supply. The daily shows a clean higher-low at $142-$147 (52-week low $142.13) followed by a sharp 22% rip back to $174, now testing the declining structure that capped price in mid-July; SMA20 +5.9%, SMA50 +0.8%, but SMA200 still -26.5% — the medium-term trend has not turned. RSI 54 is neutral, room in either direction. The 1h chart shows price stalling at $172-$176 supply, and the model's 1h forecast band actually points down toward $164-$168 over the next few sessions — notable because the 4h and 1d bands point up to $207-$212 (a well-known unreliable extrapolation on this name, and both 1d/1wk directional accuracies are BELOW naive baseline, so those bull bands should be heavily discounted). Key levels: support $158 (gap), then $142-$147 (must-hold weekly close); resistance $180, then $195-$200, with the $210-$220 gap the real supply shelf. Short float 23.2% is a squeeze setup if earnings deliver.
Signal: The July 8 finalization of the $900M fixed-price DOE task order (part of the $1.07B enrichment agreement) is the anchor event of the quarter — it moves Piketon from demo to commercial-scale HALEU, which is the entire long-term thesis. Truist initiated Buy with a $215 PT on July 15, and analyst recom sits at 1.67 (Buy) with mean target $262 — Street is constructive. Institutional ownership jumped from 71.5% to 78.4% (+6.8pp), a material bullish positioning signal that likely explains a chunk of the bounce off $142. Noise/caveat: Needham cut PT from $314→$264 and BofA cut $240→$205 on July 9, both maintaining prior ratings — even bulls are trimming targets. Broader nuclear tape (Oklo/CEG/VST commentary, SMR narrative) remains supportive but is not new information. Retail sentiment is 100% bullish across a small sample — a contrarian yellow flag into a binary print.
- $900M DOE fixed-price task order (finalized July 8) funds Piketon transition from demonstration to large-scale commercial HALEU production — the primary 2026-2027 execution catalyst
- S&P SmallCap 600 inclusion provides persistent passive bid; institutional ownership climbed +6.8pp to 78.4% in 45 days, indicating active accumulation on top of that
- Sole U.S.-licensed HALEU enricher positions Centrus as gatekeeper to Oklo, X-energy, TerraPower and other SMR/advanced reactor programs targeting 2027-2030 commercialization
- $1.87B cash / $94.97 per share funds multi-year capex without immediate dilution assuming ATM shelf stays dormant
- Q1'26 41% gross margin, if repeatable on Aug 4, would validate a path to sustained operating profitability and re-rate the forward multiple
- Aug 4 binary earnings print with Q1'26's 41% gross margin unproven for repeatability — Q3'25 was -5.7%, showing wide variance
- Forward P/E 44x and EV/EBITDA 67x offer essentially no cushion if margins revert or capex guidance disappoints
- Persistent FCF burn (-$58M in Q1'26, -$58M in Q4'25) into Piketon capex; ATM shelf remains a latent dilution overhang
- Model directional accuracy running below naive baseline on both 1d (43% vs 59%) and 1wk (33% vs 67%) — bullish forecast bands to $207-$212 should be heavily discounted
- Short float 23.2% cuts both ways — squeeze fuel on a beat, accelerant on a miss
- SMR commercialization timeline (2027-2030) is the demand thesis; any slip removes the growth runway justifying current multiple
- Heavy overhead supply from $250-$380 range means multi-quarter basing is more likely than a V-recovery to old highs
- Retail sentiment 100% bullish into a binary print is a contrarian yellow flag
Get AI analysis on any stock
This is one of hundreds of Kronos AI reports — scored fundamentals & technicals, bull/base/bear price targets, a multi-horizon plan, and continuously-updated forecasts across the market. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord